![Chris Storgard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 30/06/2026
Chris M.
Storgard is currently Chief Medical Officer at Design Therapeutics, Inc. since 2025.
Formerly, Dr. Storgard was Chief Medical Officer at Heron Therapeutics, Inc. from 2019 to 2024, Chief Medical Officer at Fate Therapeutics, Inc. from 2016 to 2018, Vice President-Clinical Research & Development at Ardea Biosciences, Inc. from 2013 to 2016, Member & Assistant Professor at Mayo Medical School from 2001 to 2004, and Chief Medical Officer at ADARx Pharmaceuticals, Inc. Dr. Storgard earned a doctorate from the University of Saskatchewan.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| DESIGN THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 17/04/2025 |
| Società | Posizione | Fine |
|---|---|---|
| HERON THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/03/2024 |
| FATE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 05/11/2018 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Direttore Tecnico/Scientifico/R&S | 02/01/2016 |
Mayo Medical School
 Mayo Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 02/01/2004 |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
University of Saskatchewan
 University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Mayo Medical School
Mayo Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Design Therapeutics, Inc.
 Design Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops therapies for serious degenerative disorders | Health Technology |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
